Skip to main content

Usana Health Sciences Inc

USNA
Exchange
NYSE
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0000896264

No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Usana Health Sciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Usana Health Sciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Usana Health Sciences Inc
NameTitleLast reported holdingLast filingFilings, past year
Benedict PeterCHIEF INFORMATION OFFICER422Jul 27, 20266
Armstrong Kathryn MichelleCHIEF SCIENTIFIC OFFICER3,471Jul 27, 20263
Wood Timothy EDirector11,837Jul 27, 20265
Winssinger Frederic JDirector9,733Jul 27, 20266
Nixon J ScottDirector11,445Jul 27, 20265
Fuller Gilbert ADirector1,632Jul 27, 20268
Pelosi PeggieDirector6,061Jul 27, 20265
Fleming John TurmanDirector5,862Jul 27, 20267
Ding XiaDirector8,278Jul 27, 20265
Neidig BrentCHIEF COMMERCIAL OFFICER0Jun 18, 20265
Jones Paul A.CHIEF PEOPLE OFFICER0Jun 8, 20265
Iiekking G DougCHIEF FINANCIAL OFFICER0May 28, 20264
Foukas JoshuaCHIEF LEGAL OFFICER0May 8, 20264
Guest KevinCEO & EXEC. CHAIRMAN OF BOARD45,381Mar 3, 20263
Noot WalterCHIEF OPERATING OFFICER9,256Mar 3, 20263
Mulham David MulhamCHIEF SALES OFFICER8,387Dec 11, 20251
Wentz Myron W10% Owner7,408,345IndirectSep 5, 20250
Gull Global Ltd10% Owner7,408,345IndirectSep 5, 20250
Brown JimCEO & PRESIDENT16,934Jul 28, 20250
Macuga Daniel A.CHIEF COMMUNICATIONS OFFICER0May 6, 20240
Sinnott Robert ACHIEF SCIENTIFIC OFFICER0Mar 5, 20240
Auciaux RobertDirector8,092May 11, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 3, 2026 (view filing)Mar 3Same dayBenedict PeterCHIEF INFORMATION OFFICERSSale−4.55K$19.38−$88.2K−100.0%0 after
Mar 20, 2026 (view filing)Mar 20Same dayFuller Gilbert ADirectorSSale−1.06K$17.00−$18.0K−100.0%0 after
May 8, 2026 (view filing)May 71 dayFoukas JoshuaCHIEF LEGAL OFFICERSSale−3.79K$19.82−$75.1K−100.0%0 after
May 26, 2026 (view filing)May 224 daysFuller Gilbert ADirectorSSale−1.06K$18.66−$19.7K−100.0%0 after
May 28, 2026 (view filing)May 271 dayIiekking G DougCHIEF FINANCIAL OFFICERSSale−5.36K$18.75−$100.5K−100.0%0 after
May 29, 2026 (view filing)May 281 dayJones Paul A.CHIEF PEOPLE OFFICERSSale−6.81K$18.95−$129.1K−55.1%5.56K after
Jun 1, 2026 (view filing)Jun 1Same dayFleming John TurmanDirectorSSale−2.45K$17.93−$43.9K−36.7%4.23K after
Jun 8, 2026 (view filing)Jun 8Same dayJones Paul A.CHIEF PEOPLE OFFICERSSale−5.56K$18.50−$102.9K−100.0%0 after
Jun 16, 2026 (view filing)Jun 12-154 daysNeidig BrentCHIEF COMMERCIAL OFFICERSSale−2.51K$20.10−$50.5K−33.4%5.00K after2 lots
Jun 18, 2026 (view filing)Jun 162 daysNeidig BrentCHIEF COMMERCIAL OFFICERSSale−5.00K$19.45−$97.3K−100.0%0 after